Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

FHS
May 16, 2024
12:09 pm

Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced the initiation of their OptiZest study, ID: NCT06372470, and first patient recruitment.

Filament Health Announces FDA Opening of Investigational New Drug Application for Substance Use Disorders | Psychedelic Invest

VANCOUVER, BC, Jan. 31, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, today

January 31, 2024

MedPage Today’s Most-Read Stories of 2023

This year was a big year in medical news, with groundbreaking drug approvals, unusual patient cases, and unprecedented changes to the healthcare workplace. As 2023

December 23, 2023

Denali’s $500M placement; Brain health startup raises $26M

Plus, news about Healis Therapeutics, NRx Pharmaceuticals, and Nuvalent: Denali Therapeutics’ $500M PIPE: The company is selling nearly 30 million shares at $17.06 apiece. Baker

February 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.